Molecular classification of endometrial cancer: entering an era of precision medicine.
作者信息
Goulder Alison, Gaillard Stéphanie L
机构信息
Johns Hopkins Department of Gynecology and Obstetrics, Baltimore, MD, USA.
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
出版信息
J Gynecol Oncol. 2022 May;33(3):e47. doi: 10.3802/jgo.2022.33.e47.
Abstract
摘要
相似文献
1
Molecular classification of endometrial cancer: entering an era of precision medicine.子宫内膜癌的分子分类：步入精准医学时代。
J Gynecol Oncol. 2022 May;33(3):e47. doi: 10.3802/jgo.2022.33.e47.
2
Lumping and splitting: The need for precision medicine and "personomics" in endometrial cancer.归并与细分：子宫内膜癌中精准医学和“个体组学”的必要性。
J Gynecol Oncol. 2021 Mar;32(2):e38. doi: 10.3802/jgo.2021.32.e38.
3
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.子宫内膜癌的分子分类：不断变化的格局中精准肿瘤学的机遇。
Cancer. 2022 Aug 1;128(15):2853-2857. doi: 10.1002/cncr.34328. Epub 2022 Jun 3.
4
Precision medicine in endometrial cancer.
Gynecol Oncol. 2019 Sep;154(3):451-453. doi: 10.1016/j.ygyno.2019.08.001.
5
Summary of the 2013 American Association for Cancer Research (AACR) Annual Meeting.
Gynecol Oncol. 2013 Jul;130(1):6-8. doi: 10.1016/j.ygyno.2013.05.031.
6
Classification of endometrial carcinoma: more than two types.子宫内膜癌的分类：不止两种类型。
Lancet Oncol. 2014 Jun;15(7):e268-78. doi: 10.1016/S1470-2045(13)70591-6.
7
Cancer genomics and clinical practice: how can we close the gap more quickly?癌症基因组学与临床实践：我们如何能更快缩小差距？
Curr Opin Obstet Gynecol. 2017 Feb;29(1):1-3. doi: 10.1097/GCO.0000000000000341.
8
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.子宫内膜癌新型分类系统的兴起；分子亚类的整合。
J Pathol. 2018 Apr;244(5):538-549. doi: 10.1002/path.5034. Epub 2018 Feb 28.
9
Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options.子宫内膜癌的治疗靶点与机遇：内分泌治疗及非免疫治疗靶向方案的最新进展
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-11. doi: 10.1200/EDBK_280495.
10
Genetic landscape of clear cell endometrial cancer and the era of precision medicine.透明细胞子宫内膜癌的遗传图谱与精准医学时代
Cancer. 2017 Sep 1;123(17):3216-3218. doi: 10.1002/cncr.30743. Epub 2017 May 9.
引用本文的文献
1
PCAF acetylates AIB1 to form a transcriptional coactivator complex to promote glycolysis in endometrial cancer.PCAF使AIB1发生乙酰化，形成转录共激活因子复合物，以促进子宫内膜癌中的糖酵解。
Front Oncol. 2024 Sep 5;14:1442965. doi: 10.3389/fonc.2024.1442965. eCollection 2024.
2
The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review.弗林蛋白酶及其抑制剂在子宫内膜腺癌中的潜在作用：一篇叙述性综述。
Cancer Rep (Hoboken). 2024 Jan;7(1):e1920. doi: 10.1002/cnr2.1920. Epub 2023 Nov 28.
3
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution.子宫体中肾样腺癌：对来自单一机构的17例连续病例进行基因组和免疫组织化学分析及全面临床病理分析
Biomedicines. 2023 Aug 15;11(8):2269. doi: 10.3390/biomedicines11082269.
4
Construction and Validation of a Prognostic Risk Prediction Model for Lactate Metabolism-Related lncRNA in Endometrial Cancer.构建和验证与子宫内膜癌中乳酸代谢相关 lncRNA 的预后风险预测模型。
Biochem Genet. 2024 Apr;62(2):741-760. doi: 10.1007/s10528-023-10443-4. Epub 2023 Jul 10.
5
Bio-Inorganic Layered Double Hydroxide Nanohybrids in Photochemotherapy: A Mini Review.生物-无机层状双氢氧化物纳米杂化在光化疗中的应用：小型综述。
Int J Mol Sci. 2022 Oct 6;23(19):11862. doi: 10.3390/ijms231911862.
本文引用的文献
1
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.POLE 突变型高级别子宫内膜癌的临床病理及分子特征：一项单中心研究。
J Gynecol Oncol. 2022 May;33(3):e38. doi: 10.3802/jgo.2022.33.e38. Epub 2022 Feb 3.
2
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.通过靶向下一代测序和癌症基因组图谱（TCGA）数据集分析晚期子宫内膜癌的基因组景观。
J Gynecol Oncol. 2022 May;33(3):e29. doi: 10.3802/jgo.2022.33.e29. Epub 2022 Jan 24.
3
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.帕博利珠单抗治疗微卫星高度不稳定型晚期子宫内膜癌患者：KEYNOTE-158 研究结果。
J Clin Oncol. 2022 Mar 1;40(7):752-761. doi: 10.1200/JCO.21.01874. Epub 2022 Jan 6.
4
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.美国国立综合癌症网络（NCCN）指南见解：子宫肿瘤，2021年第3版
J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. doi: 10.6004/jnccn.2021.0038.
5
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer.分子病理学在指导子宫内膜癌全身治疗中的新作用。
Ther Adv Med Oncol. 2021 Aug 14;13:17588359211035959. doi: 10.1177/17588359211035959. eCollection 2021.
6
Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.子宫内膜癌的分子分类与新兴靶向治疗
Int J Gynecol Pathol. 2020 Jan;39(1):26-35. doi: 10.1097/PGP.0000000000000585.
7
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.子宫内膜癌新型分类系统的兴起；分子亚类的整合。
J Pathol. 2018 Apr;244(5):538-549. doi: 10.1002/path.5034. Epub 2018 Feb 28.
8
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.NRG Oncology/GOG 关于子宫内膜样腺癌风险预测的分子分类研究。
Gynecol Oncol. 2018 Jan;148(1):174-180. doi: 10.1016/j.ygyno.2017.10.037. Epub 2017 Nov 11.
9
A clinically applicable molecular-based classification for endometrial cancers.一种适用于临床的子宫内膜癌分子分类方法。
Br J Cancer. 2015 Jul 14;113(2):299-310. doi: 10.1038/bjc.2015.190. Epub 2015 Jun 30.
10
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.优化高危子宫内膜癌的预后评估并确定可靶向治疗的途径；一项TransPORTEC计划。
Mod Pathol. 2015 Jun;28(6):836-44. doi: 10.1038/modpathol.2015.43. Epub 2015 Feb 27.
Zotero 插件